ImageneBio Inc

NASDAQ:IMA

Biotechnology

Healthcare
$4.61 +6.06%

+$0.35 today

Market cap
$52.00M
Beta
0.72
P/E (TTM)
-1.5
EPS (TTM)
-$4.02
52W Low $3.94High $18.00

Volume 0.00M

Average 0.35M

Returns on capital

ImageneBio Inc management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-34.1%

avg -0.8%

ROIC

-33.4%

avg -58.6%

ROA

-29.6%

avg -48.5%

Analysis

ROA is currently the strongest return metric at -29.6% versus its period average of -48.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Kristin Yarema

CEO & DirectorUSD 710.35K55137.20K1.22%

Benjamin Porter-Brown

Chief Medical OfficerUSD 588.36K530<0.01%

Kurinji Pandiyan

Chief Strategy & Operations Officer————

Matt Robbins

General Counsel————

Yanina Grant-Huerta

CFO, Principal Financial Officer & Principal Accounting Officer—4956.00K0.50%

Renuka Sivendran

Chief Technical Officer————

Compensation is shown in the reported currency; data updated Oct 3, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 14, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

5

$97,282.58

Sells

2

$17,334.00

Net Transaction Value

+$79,948.58

Net buying

Most Active

Lally Robert B

2 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Jul 17, 26

Lally Robert B

Direct

Sell$8.1K
Jul 16, 26

Lally Robert B

Direct

Sell$9.2K
Apr 14, 26

Bonita David P

Indirect

Buy$384.7
Apr 14, 26

ORBIMED ADVISORS LLC

Indirect

Buy$384.7
Apr 14, 26

ORBIMED ADVISORS LLC

Indirect

Buy$336.6
Apr 14, 26

Bonita David P

Indirect

Buy$336.6
Dec 24, 25

SLATTERY JOSEPH P

Direct

Buy$95.8K

Summary

Insiders reported 5 buys worth $97,282.58 and 2 sells worth $17,334.00 over the last 12 months. That adds up to net buying of $79,948.58. Lally Robert B was the most active insider with 2 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A-62.9%
+91.3% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at -62.9% over three years. Forward estimates point to Revenue at +91.3% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does ImageneBio Inc compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about IMA's management, answered from reported figures.

Who manages IMA?

ImageneBio Inc (IMA) lists 6 active executives. The top listed executive is Kurinji Pandiyan, Chief Strategy & Operations Officer.

Are IMA insiders buying or selling?

Recent insider activity shows net buying of $33.01M.